Michiko N. Fukuda

Michiko N. Fukuda

Auto-generated profile, based on publicly available information

Michiko N. Fukuda

Sanford-Burnham Medical Research Institute

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 November 2011 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
SHShingo Hatakeyama
Shingo Hatakeyama
KSKazuhiro Sugihara
Kazuhiro Sugihara
TSToshiaki K. Shibata
Toshiaki K. Shibata
JNJun Nakayama
Jun Nakayama
TATomoya O. Akama
Tomoya O. Akama
MFMichiko N. Fukuda
Michiko N. Fukuda
Although numerous carbohydrates play significant roles in mammalian cells, carbohydrate-based drug discovery has not been explored due to the technical difficulty of chemically synthesizing complex carbohydrate structures. Previously, we identified a series of carbohydrate mimetic peptides and found that a 7-mer peptide, designated I-peptide, inhibits hematogenous carbohydrate-dependent cancer cell colonization. During analysis of the endothelial surface receptor for I-peptide, we found that I-peptide bound to annexin 1 (Anxa1). Because Anxa1 is a highly specific tumor vasculature surface marker, we hypothesized that an I-peptide-like peptide could target anticancer drugs to the tumor vasculature. This study identifies IFLLWQR peptide, designated IF7, as homing to tumors. When synthetic IF7 peptide was conjugated to fluorescent Alexa 488 (A488) and injected intravenously into tumor-bearing mice, IF7-A488 targeted tumors within minutes. IF7 conjugated to the potent anticancer drug SN-38 and injected intravenously into nude mice carrying human colon HCT116 tumors efficiently suppressed tumor growth at low dosages with no apparent side effects. These results suggest that IF7 serves as an efficient drug delivery vehicle by targeting Anxa1 expressed on the surface of tumor vasculature. Given its extremely specific tumor-targeting activity, IF7 may represent a clinically relevant vehicle for anticancer drugs.

13 June 2006 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
TATomoya O. Akama
Tomoya O. Akama
HNHiroaki Nakagawa
Hiroaki Nakagawa
NWNyet Kui Wong
Nyet Kui Wong
MSMark Sutton-Smith
Mark Sutton-Smith
ADAnne Dell
Anne Dell
MFMichiko N. Fukuda
Michiko N. Fukuda
Many proteins synthesized through the secretory pathway receive posttranslational modifications, including N -glycosylation. α-Mannosidase II (MII) is a key enzyme converting precursor high-mannose-type N -glycans to matured complex-type structures. Previous studies showed that MII-null mice synthesize complex-type N -glycans, indicating the presence of an alternative pathway. Because α-mannosidase IIx (MX) is a candidate enzyme for this pathway, we asked whether MX functions in N -glycan processing by generating MII/MX double-null mice. Some double-nulls died between embryonic days 15.5 and 18.5, but most survived until shortly after birth and died of respiratory failure, which represents a more severe phenotype than that seen in single-nulls for either gene. Structural analysis of N -glycans revealed that double-nulls completely lack complex-type N -glycans, demonstrating a critical role for at least one of these enzymes for effective N -glycan processing. Recombinant mouse MX and MII showed identical substrate specificities toward N -glycan substrates, suggesting that MX is an isozyme of MII. Thus, either MII or MX can biochemically compensate for the deficiency of the other in vivo , and either of two is required for late embryonic and early postnatal development.

10 October 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
PQPAULA QUINTERO-RONDEROS
PAULA QUINTERO-RONDEROS
EMEric Mercier
Eric Mercier
MFMichiko Fukuda
Michiko Fukuda
RGRonald González
Ronald González
CSCarlos Suárez
Carlos Suárez
PLPaul Laissue
Paul Laissue
Recurrent pregnancy loss is a frequently occurring human infertility-related disease affecting ~1% of women. It has been estimated that the cause remains unexplained in >50% cases which strongly suggests that genetic factors may contribute towards the phenotype. Concerning its molecular aetiology numerous studies have had limited success in identifying the disease’s genetic causes. This might have been due to the fact that hundreds of genes are involved in each physiological step necessary for guaranteeing reproductive success in mammals. In such scenario, next generation sequencing provides a potentially interesting tool for research into recurrent pregnancy loss causative mutations. The present study involved whole-exome sequencing and an innovative bioinformatics analysis, for the first time, in 49 unrelated women affected by recurrent pregnancy loss. We identified 27 coding variants (22 genes) potentially related to the phenotype (41% of patients). The affected genes, which were enriched by potentially deleterious sequence variants, belonged to distinct molecular cascades playing key roles in implantation/pregnancy biology. Using a quantum chemical approach method we established that mutations in MMP-10 and FGA proteins led to substantial energetic modifications suggesting an impact on their functions and/or stability. The next generation sequencing and bioinformatics approaches presented here represent an efficient way to find mutations, having potentially moderate/strong functional effects, associated with recurrent pregnancy loss aetiology. We consider that some of these variants (and genes) represent probable future biomarkers for recurrent pregnancy loss.

6 March 2007 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
KSKazuhiro Sugihara
Kazuhiro Sugihara
DSDaijiro Sugiyama
Daijiro Sugiyama
JBJames Byrne
James Byrne
DWDon P. Wolf
Don P. Wolf
KLKevin P. Lowitz
Kevin P. Lowitz
MFMichiko N. Fukuda
Michiko N. Fukuda
During human embryo implantation, trophectoderm mediates adhesion of the blastocyst to the uterine epithelium. The rapid growth of the embryo and invasion of the maternal tissue suggest adhesion-induced activation of the embryonal cells. We show here that ligation of trophinin, a homophilic cell adhesion molecule expressed on trophoblastic cells, induces tyrosine phosphorylation in trophinin-expressing trophoblastic HT-H cells. The phosphorylation could be induced in HT-H cells with the binding of trophinin-expressing cells or anti trophinin antibodies. Trophinin-dependent tyrosine phosphorylation was associated with actin reorganization. We also isolated trophinin-binding peptides from phage libraries. These peptides exhibited the consensus sequence GWRQ and seemed to reproduce the effects of trophinin-mediated cell adhesion. Upon binding of a GWRQ peptide, HT-H cells became highly proliferative and motile. HT-H cells expressed ErbB family receptors and bound EGF and heparin-binding EGF-like growth factor (HB-EGF), but ErbB family receptor phosphorylation in these cells required GWRQ. In the absence of GWRQ, trophinin interacted with the cytoplasmic protein bystin, which binds to ErbB4 and blocks its autophosphorylation. In HT-H cells, GWRQ peptide dissociated trophinin from bystin, and ErbB4 was activated. Culturing monkey blastocysts in the presence of the peptide increased total number and motility of the trophectoderm cells. These results suggest that trophinin-mediated cell adhesion functions as a molecular switch for trophectoderm activation in human embryo implantation.

3 March 2009 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
SHShingo Hatakeyama
Shingo Hatakeyama
KSKazuhiro Sugihara
Kazuhiro Sugihara
JNJun Nakayama
Jun Nakayama
TATomoya O. Akama
Tomoya O. Akama
SWShuk-Man Annie Wong
Shuk-Man Annie Wong
MFMichiko N. Fukuda
Michiko N. Fukuda
Cell surfaces of epithelial cancer are covered by complex carbohydrates, whose structures function in malignancy and metastasis. However, the mechanism underlying carbohydrate-dependent cancer metastasis has not been defined. Previously, we identified a carbohydrate-mimicry peptide designated I-peptide, which inhibits carbohydrate-dependent lung colonization of sialyl Lewis X-expressing B16-FTIII-M cells in E/P-selectin doubly-deficient mice. We hypothesized that lung endothelial cells express an unknown carbohydrate receptor, designated as I-peptide receptor (IPR), responsible for lung colonization of B16-FTIII-M cells. Here, we visualized IPR by in vivo biotinylation, which revealed that the major IPR is a group of 35-kDa proteins. IPR proteins isolated by I-peptide affinity chromatography were identified by proteomics as Ser/Arg-rich alternative pre-mRNA splicing factors or Sfrs1 , Sfrs2 , Sfrs5 , and Sfrs7 gene products. Bacterially expressed Sfrs1 protein bound to B16-FTIII-M cells but not to parental B16 cells. Recombinant Sfrs1 protein bound to a series of fucosylated oligosaccharides in glycan array and plate-binding assays. When anti-Sfrs antibodies were injected intravenously into mice, antibodies labeled a subset of lung capillaries. Anti-Sfrs antibodies inhibited homing of I-peptide-displaying phage to the lung colonization of B16-FTIII-M cells in vivo in the mouse. These results strongly suggest that Sfrs proteins are responsible for fucosylated carbohydrate-dependent lung metastasis of epithelial cancers.

15 April 2008 in Journal of Obstetrics and Gynaecology Research
Verified
Journal Article
Open access
PDF file
MFMichiko N. Fukuda
Michiko N. Fukuda
KSKazuhiro Sugihara
Kazuhiro Sugihara
Determining molecular mechanisms of human embryo implantation is an extremely challenging task due to the limitation of materials and significant differences underlying this process among mammalian species. Recently, L‐selectin and its ligand carbohydrate have been proposed as a system that mediates initial adhesion of human blastocysts to the uterine epithelia. We have also identified trophinin as a unique apical cell adhesion molecule potentially involved in the initial adhesion of trophectoderm of the human blastocyst to endometrial surface epithelia. In the mouse, the binding between ErbB4 on the blastocyst and heparin‐binding epidermal growth factor‐like growth factor on the endometrial surface enables the initial step of the blastocyst implantation. The evidence suggests that L‐selectin and trophinin are included in human embryo implantation. This review summarizes findings relevant to the functions of L‐selectin and trophinin in human embryo implantation, and proposes a model that reconciles these cell adhesion mechanisms.